3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
48
Phase 1/2
29
Phase 2
8
Phase NA
3
Phase EARLY_PHASE1
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
85
Gynecologic
2
Gastrointestinal
2
Head & Neck
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Melanoma
158
Keratosis, Actinic
75
Lymphoma, T-Cell, Cutaneous
36
Skin Neoplasms
27
Mycosis Fungoides
27
Lymphoma, Non-Hodgkin
25
Lymphoma, Mantle-Cell
25
Lymphoma, Large-Cell, Immunoblastic
25
Lymphoma, Large B-Cell, Diffuse
25
Lymphoma, Follicular
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Hodgkin Disease
25
Sezary Syndrome
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, B-Cell, Marginal Zone
24
Burkitt Lymphoma
24
Neoplasms
22
Carcinoma, Basal Cell
22
Neoplasm Metastasis
20
Multiple Myeloma
20
Leukemia, Myeloid, Chronic-Phase
20
Leukemia, Myeloid, Accelerated Phase
20
Leukemia, Hairy Cell
20
Leukemia, Myeloid, Acute
19
Blast Crisis
19
Primary Myelofibrosis
18
Lymphoma
18
Uveal Melanoma
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Large-Cell, Anaplastic
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Triple Negative Breast Neoplasms
×
Dermatologic
×
Clear all
NCT05078047
2025-06-05
MOIO
UNICANCER
Phase 3
Recruiting
646 enrolled